Israel's Therapix Biosciences to be acquire for $48M
Note: This section contains information in English only.
Tue, 23 Oct 2018 09:34:35 GMT
Source: Dukascopy Bank SA
Canada's FSD Pharma is planning to acquire the Israeli firm Therapix Biosciences in an all=stock deal worth $48M that would combine two complementary units focused on the R&D of cannabinoid treatments.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.